نتائج البحث 1221-1230 من 14792 لعملية البحث عن treatment resistant depression
In December 2024, the FDA approved a mesenchymal stem cell therapy for children with a serious condition called steroid-refractory graft-versus-host disease.
Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used. ... resistance to immune ...
... drug-resistant epilepsy · ابتكارات في رعاية الصرع: بدائل للأدوية تسعى إلى إعادة ضبط الد?...اغ وإصلاحه، ك?...ا يوضح الباحثون · Mayo Clinic physicians map ...
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
(i.e., who were not treated pre-surgically). PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk ...
ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.
Patients will have imaging performed per standard of care. Primary Goal. To evaluate the incidence of immune checkpoint inhibitors (ICI)-induced colitis (IIC) ...
Rochester, Minn. The purposes of this study are to determine if patients treated with fluoroquinolone (FQ) antibiotics have depletion of mitochondrial DNA ( ...
... treatment. A Study Of Change In Imaging Biomarkers Of Dementia With Lewy Bodies (DLB) And Associations With Cognitive And Functional Decline. Rochester, Minn ...
... treatment) in the breast in patients who have been treated with chemotherapy and have had follow-up radiation therapy (but not surgery) and are in complete ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.